Eli Lilly and Company logo

Advisor – RNA Preclinical Pharmacology, Ocular

Eli Lilly and Company

Boston, MAOnsitePosted 3 days ago$141,000 - $231,000/year
Full TimeEntry LevelResearch & ScientistPharmaceutical
Original posting ↗

Summary

The successful candidate will establish and lead a new ocular and sensory in vivo pharmacology capability within the RNA In Vivo Pharmacology group. They will bring a strong research track record in ocular pharmacology, with an emphasis on the retina, and demonstrated experience advancing genetic medicines in the eye. As the group's subject matter expert in ocular and sensory biology, they will define the in vivo strategy for this therapeutic area, build the models, endpoints, and workflows required to support it, and collaborate within a multidisciplinary team spanning oligonucleotide chemistry, delivery, translational biology, toxicology, and clinical development to advance next-generation RNA-based therapeutics for retinal and other sensory diseases.

Job description

Key Responsibilities

  • Establish the ocular/sensory in vivo pharmacology capability from the ground up, including species and model selection, animal use protocols, SOPs, imaging and functional-testing infrastructure, and training team members
  • Represent ocular RNA therapeutics on cross functional project teams to drive programs from target validation through candidate selection and IND-enabling studies
  • Design, plan, and implement in vivo ocular pharmacology studies in rodents, and design and oversee large-animal studies with external partners, to define PK/PD, ocular biodistribution, duration of action, and tolerability of siRNA and ASO molecules
  • Perform and optimize ocular dosing routes, including intravitreal and topical/periocular administration, and partner with chemistry and delivery teams to inform route, formulation, and dose selection
  • Lead ocular sample collection and dissection, including aqueous and vitreous humor sampling and isolation of retina, RPE/choroid, optic nerve, and other ocular tissues for molecular, bioanalytical, and histological endpoints
  • Implement and interpret in-life ocular endpoints, including ophthalmic examination, intraocular pressure, optical coherence tomography (OCT), fundus imaging, and electroretinography (ERG)
  • Expertise in ocular tissue processing for target engagement and distribution endpoints (e.g., RT-qPCR, in situ hybridization, immunohistochemistry, ELISA, oligonucleotide quantification, novel assay development), with an emphasis on retinal layer- and cell type-resolved readouts
  • Establish and validate disease-relevant retinal models (e.g., inherited or induced retinal degeneration, neovascular, inflammatory, and optic neuropathy models) to demonstrate pharmacodynamic and functional efficacy
  • Shape translational strategy for ocular programs, including cross-species dose scaling, PK/PD inputs, and biomarker approaches, in conjunction with DMPK, toxicology, and clinical teams
  • Identify, evaluate, and manage CROs and academic collaborators with specialized ocular and sensory capabilities
  • Assist in troubleshooting technical challenges for team members
  • Adherence to rigorous scientific standards, data QC, and data analysis methods
  • Provide written and verbal communication of work in lab reports and team meetings
  • Accurate recording of all practical work: completion of electronic notebook to Lilly procedure quality standards
  • General laboratory assistance, including ordering and receiving lab supplies, preparation of reagents, and maintain laboratory equipment
  • Ensure compliance with all health and safety regulations
  • Passionate about contributing to a diverse and inclusive environment, every day

Basic Qualifications

  • PhD in pharmacology, ophthalmology, neuroscience, biology, biochemistry, or related field
  • 1+ years of post-doctoral training or industry experience
  • Hands-on experience conducting in vivo ocular pharmacology studies, including ocular dosing and retinal tissue collection

Additional Skills/Preferences

  • Direct experience advancing genetic medicines in a drug development or applied therapeutics setting, ideally siRNA or ASO programs targeting the retina; experience with gene editing, AAV gene therapy, or other genetic medicine modalities is also valued
  • Proficiency with intravitreal injection in rodents along with broader in vivo pharmacology competencies, including common systemic dosing routes and blood/tissue collection techniques
  • Hands-on experience acquiring and analyzing retinal structural and functional data (e.g., SD-OCT, fundus photography and autofluorescence, fluorescein angiography, ERG, optomotor or other visual behavior assays)
  • Understanding of retinal cell biology and ocular barriers (e.g., inner limiting membrane, blood-retinal barrier, RPE) and how they shape oligonucleotide distribution and cell type-specific uptake
  • Familiarity with ocular tolerability and safety assessment, including intraocular inflammation grading, and class considerations for intravitreally administered oligonucleotides
  • Experience designing and overseeing ocular studies in non-human primates or other large-eyed species at CROs
  • Experience with additional sensory systems (e.g., inner ear)
  • Knowledge of drug delivery, ocular pharmacokinetics, basic pharmacology concepts, and awareness of the ocular genetic medicine clinical landscape
  • Execution-focused, independent, and team-oriented, with the initiative to build a new capability and thrive in a fast-paced and innovative environment
  • Ability to adapt to changing platform needs, workflows and projects
  • Experience in processing, organizing, analyzing and visualizing data and information from disparate sources and ability to extract insight from data
  • Embrace diversity of thought, background, and experience to deliver innovative solutions

Requirements

  • PhD in pharmacology, ophthalmology, neuroscience, biology, biochemistry, or related field
  • 1+ years of post-doctoral training or industry experience
  • Hands-on experience conducting in vivo ocular pharmacology studies, including ocular dosing and retinal tissue collection
  • Proficiency with intravitreal injection in rodents
  • Experience with common systemic dosing routes and blood/tissue collection techniques
  • Hands-on experience acquiring and analyzing retinal structural and functional data
  • Understanding of retinal cell biology and ocular barriers
  • Familiarity with ocular tolerability and safety assessment
  • Experience designing and overseeing ocular studies in non-human primates or other large-eyed species at CROs
  • Knowledge of drug delivery, ocular pharmacokinetics, and basic pharmacology concepts
  • Execution-focused, independent, and team-oriented
  • Experience in processing, organizing, analyzing and visualizing data

Benefits

  • 401(k) Matching
  • Pension
  • Vacation Benefits
  • Medical, Dental & Vision
  • Prescription Drug Benefits
  • Flexible Spending Accounts
  • Life Insurance
  • Death Benefits
  • Employee Assistance Program
  • Fitness Benefits
  • Employee Clubs & Activities
  • Company Bonus

Company overview

Eli Lilly and Company, commonly known as Lilly, is a leading American multinational pharmaceutical corporation headquartered in Indianapolis, Indiana. Founded in 1876 by Colonel Eli Lilly, the company has grown into one of the world's most valuable pharmaceutical enterprises, with operations in approximately 125 countries. Lilly specializes in developing and manufacturing innovative medicines across multiple therapeutic areas, including diabetes, oncology, neuroscience, immunology, and cardiometabolic diseases. The company is renowned for its groundbreaking work in insulin production, having been the first to mass-produce insulin and later developing the first commercially available insulin product in the U.S. Lilly's current portfolio includes blockbuster medications such as Mounjaro and Zepbound (tirzepatide) for diabetes and obesity, Trulicity (dulaglutide) for type 2 diabetes, Verzenio (abemaciclib) for breast cancer, and Taltz (ixekizumab) for autoimmune conditions. With approximately 47,000 employees worldwide, Lilly maintains a strong commitment to research and development, investing heavily in scientific innovation to address some of the world's most significant health challenges. The company operates with a mission to make life better for people around the world through the discovery and delivery of innovative medicines.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.